Tuesday, July 21, 2020 7:46:14 PM
The Float Is Razor Thin
Chart Is Trending Bullish
Substantial Market Opportunity
Strong And Growing Patent Portfolio
Plans To Uplist
Expected FDA 510(k) Submission For 2nd Product
Majority of NeuroOne’s products expect US FDA 501 process.
Comapny Profile
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, essential tremors and other related neurological disorders that may improve patient outcomes and reduce procedural costs.
Why NeuroOne?
NeuroOne (OTCQB:NMTC) is a next generation electrode technology company specializing in development and commercialization of hi-definition thin film electrodes for the diagnosis and
treatment of various neurological conditions such as epilepsy, Parkinson’s Disease
and chronic pain due to failed back surgery syndrome
First FDA 510(k) clearance for cortical electrode product family December 2019
Potential ability to perform recording, ablation and stimulation with the same electrode
Minimally invasive flexible patented technology leverages printed circuit technology
We expect our technology could reduce manufacturing costs, procedural costs and improve patient outcomes
Mayo Clinic assisted in the development process, successfully used devices in humans as part of a research protocol and currently maintains an ownership position in the Company. WARF (University of Madison-Wisconsin’s Alumni Research Foundation) also assisted in development)
Well positioned electrode technology has strong potential for future use in DBS (deep brain stimulation) spinal cord stimulation and artificial intelligence applications, which may play an important future role in treating patients with more complex neurological issues
Experienced Management Team, Board of Directors and two Advisory Boards with highly acclaimed physicians from prestigious institutions
Strong and growing patent portfolio(MI tool, drug delivery, spinal cord stim )
The Bottom Line
With its low-float and recent announcements, we believe that NMTC is in for a huge day of trading.
The Company is in the midst of a major growth period, and we believe it has the potential to double in price from here.
Having been granted the regulatory green light to begin bringing its product line to market, Neuro-One’s stock is still ranging within its lows (currently at around $2.00 per share). This shouldn’t come as a surprise, as the emerging healthcare space is often too specialized a sub-industry for most mainstream investors to monitor let alone understand.
But for the few who can grasp both the relevance and growth potential of Neuro-One’s product line, the company offers early investors an opportunity to get in on a much-needed medical product that, to date, sees neither comparable solutions nor formidable competition.
Traders looking for a company that is committed to growth, and with plenty of upside should add NMTC to the top of their watchlist immediately..By Viewing this Content, you Agree that you Have Read and are in Full Understanding of both our Disclaimer & Privacy Policy(*Remember to use a Stop-Loss Order to protect your gains, as well as limit possible losses.)
Best Regards
Official InvestorsHub (IHUB) Profile for #TFMG | #theFinancialMarketingGroup:
#BullishCharts - https://investorshub.advfn.com/BullishChartscom-38003/
#TopMarketGainers - https://investorshub.advfn.com/Chart-Analysis-TopMarketGainerscom-36847/
Recent NMTC News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/16/2024 04:15:05 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2024 08:30:27 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/12/2024 01:03:52 PM
- NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland • GlobeNewswire Inc. • 09/10/2024 01:00:00 PM
- NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/05/2024 10:23:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 03:43:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 03:36:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 03:26:56 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/30/2024 08:31:07 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/16/2024 08:30:40 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/14/2024 08:34:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:15:28 PM
- NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/14/2024 08:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 12:59:13 PM
- NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14 • GlobeNewswire Inc. • 08/12/2024 03:30:00 PM
- NeuroOne® Announces $2.65 Million Equity Financing And $3.0 Million Credit Facility • GlobeNewswire Inc. • 08/05/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 06:38:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 06:31:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 06:16:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 08:49:49 PM
- NeuroOne® Announces First in Human Ablations Completed with OneRF™ Ablation System • GlobeNewswire Inc. • 06/25/2024 01:00:00 PM
- NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation • GlobeNewswire Inc. • 06/20/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 07:34:41 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM